CVE-2020-12040Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication c…
Updated under an hour ago ()
Does this affect you?
It affects baxter sigma_spectrum_infusion_system_firmware. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.95%, higher than 60% of scored CVEs.
Do this next
Free account, 1 product
Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication channel to send and receive system status and operational data. This could allow an attacker that has circumvented network security measures to view sensitive non-private data or to perform a man-in-the-middle attack.
- CVSS
- 9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-319
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.95% (percentile 60)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 4, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
baxter sigma_spectrum_infusion_system_firmware baxter:sigma_spectrum_infusion_system_firmware | from 6.0 through 6.05; 8.0 | NVD |
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-04x-refsource-misc, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.